Paradowska Edyta相关文献与解析，生知库 | 链接生命科学的每一步

Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer

预测化疗耐药性——临床前数据如何帮助改进高级别浆液性卵巢癌的治疗策略

期刊:Current Oncology

影响因子:3.4

doi:10.3390/curroncol31010015

Wilczyński, Jacek; Paradowska, Edyta; Wilczyńska, Justyna; Wilczyński, Miłosz

"DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies

“DEPHENCE”系统——一种急需用于治疗高级别浆液性卵巢癌的新型疗法——重点在于抗癌干细胞和抗肿瘤微环境靶向治疗。

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2023.1201497

Wilczyński, Jacek R; Wilczyński, Miłosz; Paradowska, Edyta

Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity?

高级别浆液性输卵管卵巢癌的个体化治疗——可能性还是必要性？

期刊:Journal of Personalized Medicine

影响因子:3

doi:10.3390/jpm14010049

Wilczyński, Jacek; Paradowska, Edyta; Wilczyński, Miłosz

The Toll-like Receptor 4 Polymorphism Asp299Gly Is Associated with an Increased Risk of Ovarian Cancer

Toll样受体4多态性Asp299Gly与卵巢癌风险增加相关

期刊:Cells

影响因子:5.2

doi:10.3390/cells11193137

Kania, Katarzyna D; Haręża, Daria; Wilczyński, Jacek R; Wilczyński, Miłosz; Jarych, Dariusz; Malinowski, Andrzej; Paradowska, Edyta

Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies

卵巢癌中的癌症干细胞——肿瘤成功的来源和新型疗法的挑战性靶点

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms23052496

Wilczyński, Jacek R; Wilczyński, Miłosz; Paradowska, Edyta

Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins

人乳头瘤病毒作为妇科癌症的感染因子。病毒蛋白的致癌特性

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms23031818

Haręża, Daria A; Wilczyński, Jacek R; Paradowska, Edyta

Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC)

子宫内膜异位症干细胞可能是子宫内膜异位症相关卵巢癌（EAOC）致癌作用的主要靶点

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers15010111

Wilczyński, Jacek R; Szubert, Maria; Paradowska, Edyta; Wilczyński, Miłosz

The TLR9 2848C/T Polymorphism Is Associated with the CMV DNAemia among HIV/CMV Co-Infected Patients.

TLR9 2848C/T 多态性与 HIV/CMV 合并感染患者的 CMV DNA 血症相关

期刊:Cells

影响因子:5.2

doi:10.3390/cells10092360

JabÅoÅska Agnieszka, JabÅonowska ElÅ¼bieta, StudziÅska MirosÅawa, Kamerys Juliusz, Paradowska Edyta

其它

发表日期：2021

文献求助收藏

Lactate Suppresses Retroviral Transduction in Cervical Epithelial Cells through DNA-PKcs Modulation

乳酸通过DNA-PKcs调控抑制宫颈上皮细胞中的逆转录病毒转导

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms222413194

Wagner, Waldemar; Sobierajska, Katarzyna; Kania, Katarzyna Dominika; Paradowska, Edyta; Ciszewski, Wojciech Michał

High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive

高级别浆液性卵巢癌——风险因素之谜与筛查逃逸者

Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer

预测化疗耐药性——临床前数据如何帮助改进高级别浆液性卵巢癌的治疗策略

"DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies

“DEPHENCE”系统——一种急需用于治疗高级别浆液性卵巢癌的新型疗法——重点在于抗癌干细胞和抗肿瘤微环境靶向治疗。

Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity?

高级别浆液性输卵管卵巢癌的个体化治疗——可能性还是必要性？

The Toll-like Receptor 4 Polymorphism Asp299Gly Is Associated with an Increased Risk of Ovarian Cancer

Toll样受体4多态性Asp299Gly与卵巢癌风险增加相关

Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies

卵巢癌中的癌症干细胞——肿瘤成功的来源和新型疗法的挑战性靶点

Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins

人乳头瘤病毒作为妇科癌症的感染因子。病毒蛋白的致癌特性

Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC)

子宫内膜异位症干细胞可能是子宫内膜异位症相关卵巢癌（EAOC）致癌作用的主要靶点

The TLR9 2848C/T Polymorphism Is Associated with the CMV DNAemia among HIV/CMV Co-Infected Patients.

TLR9 2848C/T 多态性与 HIV/CMV 合并感染患者的 CMV DNA 血症相关

Lactate Suppresses Retroviral Transduction in Cervical Epithelial Cells through DNA-PKcs Modulation

乳酸通过DNA-PKcs调控抑制宫颈上皮细胞中的逆转录病毒转导